Search for Clinical Trial Results

Sponsored By

Neurofibroma, Plexiform - 11 Studies Found

Status Study
Completed Study Name: Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas
Condition:
  • Neurofibromatosis Type 1
  • Plexiform Neurofibroma
  • Date: 2011-08-08
    Interventions: Drug: RAD001: Everolimus 10 mg of RAD001 will be self-administered orally once daily continuously for on
Completed Study Name: Study of Plexiform Neurofibromas in Neurofibromatosis Type 1
Condition:
  • Plexiform Neurofibromas
  • NF1

Date: 2000-11-03
Recruiting Study Name: PLX3397 in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN)
Condition:
  • Neurofibroma, Plexiform
  • Precursor Cell Lymphoblastic Leukemia-L
    Date: 2015-03-17
    Interventions: Drug: PLX3397 Take oral drug daily for a 28 day cycle
Terminated Study Name: Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
Condition:
  • Neurofibromatosis Type 1
  • Precancerous Condition

Date: 2003-05-06
Interventions:
  • Radiation: fludeoxyglucose F 18
  • Radiation:
Completed Study Name: Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
Condition:
  • Neurofibromatosis Type 1
  • Precancerous Condition

Date: 2003-02-05
Interventions: Drug: pirfenidone
Completed Study Name: Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas
Condition:
  • Neurofibromatosis Type 1
  • Precancerous Condition

Date: 2002-02-14
Interventions:
  • Drug: Methotrexate Methotrexat
Completed Study Name: Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Condition: Cancer
Date: 2006-06-19
Recruiting Study Name: Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations
Condition: Cancer
Date: 2014-04-24
Interventions:
  • Drug: Trametinib Trametinib is
Completed Study Name: PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma
Condition:
  • Neoplasm of Uncertain Malignant Potential
  • Unspecified Childhood Solid Tumor, Protocol Specif
    Date: 2005-11-11
    Interventions: Biological: PEG-interferon alfa-2a
Recruiting Study Name: AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors
Condition:
  • Neurofibromatosis 1
  • Neurofibromatosis Type 1
  • NF 1
    • Date: 2011-05-27
    Interventions: Drug: AZD6244 AZD6244 orally every 12 hours on continuous daily schedule for cycles of 28 days until una
Next >>>